Peter C. Reifsnyder

2.8k total citations · 1 hit paper
41 papers, 2.0k citations indexed

About

Peter C. Reifsnyder is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, Peter C. Reifsnyder has authored 41 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 16 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in Peter C. Reifsnyder's work include Pancreatic function and diabetes (16 papers), Adipose Tissue and Metabolism (14 papers) and Diabetes and associated disorders (13 papers). Peter C. Reifsnyder is often cited by papers focused on Pancreatic function and diabetes (16 papers), Adipose Tissue and Metabolism (14 papers) and Diabetes and associated disorders (13 papers). Peter C. Reifsnyder collaborates with scholars based in United States, Germany and South Korea. Peter C. Reifsnyder's co-authors include Edward H. Leiter, David Serreze, Matthew S. Hanson, Sara Fleming, Don S. Varnum, Leonard D. Shultz, H.D. Chapman, Gary A. Churchill, Kevin Flurkey and Michal Procházka and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Peter C. Reifsnyder

40 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.

1996 502 citations David Serreze, H.D. Chapman et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Peter C. Reifsnyder

Since Specialization

Citations

This map shows the geographic impact of Peter C. Reifsnyder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Reifsnyder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Reifsnyder more than expected).

Fields of papers citing papers by Peter C. Reifsnyder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Reifsnyder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Reifsnyder. The network helps show where Peter C. Reifsnyder may publish in the future.

Co-authorship network of co-authors of Peter C. Reifsnyder

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Reifsnyder. A scholar is included among the top collaborators of Peter C. Reifsnyder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Reifsnyder. Peter C. Reifsnyder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of lifespan across diversity outbred mouse studies identifies multiple longevity-associated loci 2025 ·Genetics ·Martin N. Mullis, Kevin M. Wright, Anil Raj, Daniel M. Gatti, Peter C. Reifsnyder, Kevin Flurkey, Jonathan R. Archer, (unknown), Andrea Di Francesco, Karen L. Svenson, Ron Korstanje, David E. Harrison, J. Graham Ruby, Gary A. Churchill	0
2	Age associated changes in behavioral and memory functions in genetically heterogeneous mice UM‐HET3 2024 ·Alzheimer s & Dementia ·(unknown), (unknown), Peter C. Reifsnyder, Kristen M.S. O’Connell, Richard A. Miller, David E. Harrison, Catherine C. Kaczorowski	1
3	Contributions of mouse genetic strain background to age-related phenotypes in physically active HET3 mice 2024 ·Neurobiology of Aging ·(unknown), (unknown), (unknown), Michele Joana Alves, Pablo Vidal, (unknown), (unknown), Kristin I. Stanford, Juan Peng, Peter C. Reifsnyder, (unknown), W. David Arnold, Kristy L. Townsend	1
4	Age‐related changes to adipose tissue and peripheral neuropathy in genetically diverse HET3 mice differ by sex and are not mitigated by rapamycin longevity treatment 2023 ·Aging Cell ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Magdalena Blaszkiewicz, (unknown), (unknown), (unknown), (unknown), Anne Harrington, Larisa Ryzhova, Lucy Liaw, Peter C. Reifsnyder, (unknown), Kristy L. Townsend	14
5	Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J‐Lepr^db mice 2018 ·Annals of the New York Academy of Sciences ·Peter C. Reifsnyder, Sergey Ryzhov, Kevin Flurkey, Rea P. Anunciado‐Koza, Ian Mills, (unknown), Robert A. Koza	18
6	Rapamycin Ameliorates Nephropathy despite Elevating Hyperglycemia in a Polygenic Mouse Model of Type 2 Diabetes, NONcNZO10/LtJ 2014 ·PLoS ONE ·Peter C. Reifsnyder, Rosalinda Doty, (unknown)	19
7	Diet‐induced Obesity in Two C57BL/6 Substrains With Intact or Mutant Nicotinamide Nucleotide Transhydrogenase (Nnt) Gene 2010 ·Obesity ·Anthony Nicholson, Peter C. Reifsnyder, Rachel D. Malcolm, (unknown), Grant R. MacGregor, Weidong Zhang, Edward H. Leiter	135
8	Unexpected functional consequences of xenogeneic transgene expression in β‐cells of NOD mice 2007 ·Diabetes Obesity and Metabolism ·Edward H. Leiter, Peter C. Reifsnyder, John P. Driver, (unknown), Caroline Choisy-Rossi, David Serreze, Manami Hara, Alexander V. Chervonsky	13
9	Adipokine and Insulin Profiles Distinguish Diabetogenic and Non‐diabetogenic Obesities in Mice 2007 ·Obesity ·Edward H. Leiter, Peter C. Reifsnyder, Qiang Xiao, Jehangir Mistry	13
10	Targeted Disruption of CD38 Accelerates Autoimmune Diabetes in NOD/Lt Mice by Enhancing Autoimmunity in an ADP-Ribosyltransferase 2-Dependent Fashion 2006 ·The Journal of Immunology ·Jing Chen, Yi‐Guang Chen, Peter C. Reifsnyder, William Schott, Chul‐Ho Lee, Melissa Osborne, Felix Scheuplein, Friedrich Haag, Friedrich Koch‐Nolte, David Serreze, Edward H. Leiter	53
11	Differential Endocrine Responses to Rosiglitazone Therapy in New Mouse Models of Type 2 Diabetes 2005 ·Endocrinology ·Edward H. Leiter, Peter C. Reifsnyder, Weidong Zhang, (unknown), Qiang Xiao, Jehangir Mistry	20
12	Conditioning the genome identifies additional diabetes resistance loci in Type I diabetes resistant NOR/Lt mice 2005 ·Genes and Immunity ·Peter C. Reifsnyder, (unknown), Pablo A. Silveira, Gary A. Churchill, David Serreze, Edward H. Leiter	22
13	“Agouti NOD”: identification of a CBA-derived Idd locus on Chromosome 7 and its use for chimera production with NOD embryonic stem cells 2005 ·Mammalian Genome ·Jing Chen, Peter C. Reifsnyder, Felix Scheuplein, William Schott, Maria Mileikovsky, (unknown), András Nagy, (unknown), James Ellis, Friedrich Koch‐Nolte, Edward H. Leiter	18
14	Contributions of dysregulated energy metabolism to type 2 diabetes development in NZO/H1Lt mice with polygenic obesity 2004 ·Metabolism ·Robert A. Koza, Kevin Flurkey, (unknown), Christopher J. Braun, (unknown), Peter C. Reifsnyder, Leslie P. Kozak, Edward H. Leiter	28
15	Anti‐Insulin Receptor Autoantibodies Are Not Required for Type 2 Diabetes Pathogenesis in NZL/Lt Mice, a New Zealand Obese (NZO)‐Derived Mouse Strain 2004 ·Journal of Diabetes Research ·Marcia F. McInerney, Sonia M. Najjar, Deanna R. Brickley, Mary L. Lutzke, George A. Abou-Rjaily, Peter C. Reifsnyder, (unknown), Kevin Flurkey, Ying-Jian Zhang, Susan L. Pietropaolo, Massimo Pietropaolo, (unknown), Edward H. Leiter	5
16	Maternal Environment and Genotype Interact to Establish Diabesity in Mice 2000 ·Genome Research ·Peter C. Reifsnyder, Gary A. Churchill, Edward H. Leiter	143
17	B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. breakdown → 1996 ·The Journal of Experimental Medicine ·David Serreze, H.D. Chapman, Don S. Varnum, Matthew S. Hanson, Peter C. Reifsnyder, (unknown), Sara Fleming, Edward H. Leiter, Leonard D. Shultz	502
18	Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. 1994 ·The Journal of Experimental Medicine ·David Serreze, Michal Procházka, Peter C. Reifsnyder, Margot M. Bridgett, Edward H. Leiter	125
19	Typing recombinant inbred mouse strains for microsatellite markers 1993 ·Mammalian Genome ·Benjamin A. Taylor, Peter C. Reifsnyder	18
20	Linkage of the thyroid peroxidase locus (<i>Tp</i><i>o</i>) to markers in the proximal part of Chromosome 12 of the mouse 1992 ·Cytogenetic and Genome Research ·Benjamin A. Taylor, Peter C. Reifsnyder, Roberto DiLauro	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact